RSS   Newsletter   Contact   Advertise with us
Post Online Media

GW Pharma director, CMO Stephen Wright to retire

GW PharmaceuticalsGW Pharmaceuticals announced that Stephen Wright has notified the board of his intention to step down as chief medical officer and a member of the board on May 1, 2017.

Dr. Wright has served as Company's Research and Development Director since January 2004 and as a Director since March 2005. He has more than 20 years of experience in drug development.

Article continues below

READ MORE GW Pharmaceuticals appoints Cabot Brown as non-executive director

Dr. Wright was Senior Vice President of Clinical Research & Development and a member of the U.K. Board of Directors at Ipsen Limited, where he led teams responsible for regulatory success in both the United States and the European Union.

Dr. Wright also has direct U.S. drug development experience, first as Medical Director of Immunosciences, then as Venture Head of Neuroscience at Abbott Laboratories.

Dr. Wright is a Fellow of the Royal College of Physicians of Edinburgh and the Faculty of Pharmaceutical Medicine.

He is also a Visiting Professor in the School of Chemistry, Food and Pharmacy at The University of Reading and is the author of more than 100 publications, and several book chapters.

Dr. Wright received an M.D. and an M.A. in Social and Political Science from the University of Cambridge and qualified in Medicine (MBBS) at The Royal London Hospital.


 LATEST MOVES FROM United Kingdom 


 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy